Lediga tjänster
Bli en del av Novartis, här kan du se mer om vilka karriärmöjligheter som finns.
Visar 1309 resultat
- Sort by Sort ascending
- Jobbtitel Sortera stigande
- Företag
- Land
- Ort
- Publiceringsdatum
| Jobbtitel Sortera stigande | Företag | Land | Ort | Publiceringsdatum |
|---|---|---|---|---|
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Mid-West Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
| Operational Excellence (OpEx) Manager (m/f/d), temporary Temporary (Fixed Term), Full time | Production / Manufacturing | Austria | Kundl | Dec 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Gulf Coast Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
| Tehnik vzdrževanja tehničnih storitev II (m/ž/d), Ljubljana Regular, Full time | Production / Manufacturing | Slovenia | Ljubljana | Dec 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - New England Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Wisconsin Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
| Senior QA Expert ESO Temporary (Fixed Term), Full time | Quality | Poland +Alternative Locations | Warsaw | Dec 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Chicago Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Tri- State Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Central Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |